
December 23, 2024
CD40L-augmented tumor infiltrating lymphocyte expa...
Lilit Karapetyan’s Abstract Tumor infiltrating lymphocyte (TIL) therapy represents a promising approach for the treatment of patients whose disease does not benefit f...
Learn more about our upcoming Galas and Signature Events Learn More
DENVER, CO – The Melanoma Research Foundation (MRF) will host its 14th Annual Denver Gala on Thursday, September 18 at its new venue, Asterisk Denver. This year’s event...
Lilit Karapetyan’s Abstract Tumor infiltrating lymphocyte (TIL) therapy represents a promising approach for the treatment of patients whose disease does not benefit f...
Alexander Huang’s Abstract Radiation can be used as a vaccine, to increase the effect of immunotherapy. We call this Radvax, which is promising. Even in melanoma pati...
Pilot Proposal – Keiran Smalley, PhD
Sep 25, 2025 ET